Innovative Diagnostic Solutions biosurfit offers innovative medical diagnostic solutions such as the spinit® instrument, providing real-time and accurate results with just one small drop of blood. This technology can be leveraged to enhance point-of-care testing capabilities, presenting a compelling sales opportunity for healthcare facilities and clinics seeking efficient and precise diagnostic tools.
Expansion with COVID Antibody CE Marking With the recent CE Marking for its COVID Antibody test, biosurfit has expanded its product portfolio to include critical testing parameters in the current healthcare landscape. Sales representatives can capitalize on this opportunity by targeting organizations and institutions looking to enhance their COVID-19 testing capabilities with reliable and approved diagnostic solutions.
Recognition for Innovation Being recognized with an Innovation Award by the European Investment Bank positions biosurfit as a leader in the diagnostics industry. Sales teams can utilize this accolade to build credibility and trust with potential customers, highlighting the company's commitment to developing cutting-edge medical technologies that deliver impactful results.
Competitive Positioning Comparing biosurfit with similar companies like CELLINK, Fluigent, and Nanion Technologies reveals its unique value proposition. Sales professionals can emphasize biosurfit's focus on user-friendly technology and its ability to address a wide range of blood tests, showcasing a competitive advantage that resonates with healthcare providers seeking advanced diagnostic solutions.
Potential Sales Growth with Funding Despite its revenue falling in the $0-10M range, biosurfit's funding of $11M indicates investor confidence in the company's growth potential. Sales development representatives can leverage this information to engage with prospects, demonstrating biosurfit's financial stability and capacity for further product development and market expansion.
1-888-653-2347 
support@leadiq.com 
